Dana Farber Cancer Institute (Data Collection Only)

Boston, Massachusetts 02115

7 studies enrolling now · 7 studies all time

What they study most

Adult T-cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T-cell Lymphoma, BRCA1/2, Breast Implant-Associated Anaplastic Large Cell Lymphoma, Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form, Chronic Lymphoproliferative Disorder of NK Cells, Enteropathy-associated T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Follicular T-Cell Lymphoma

Studies at this site

• A Study of Enasidenib in People With T-Cell Lymphoma — Recruiting now
• A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer — Recruiting now
• A Registry for People With T-cell Lymphoma — Recruiting now
• Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes — Recruiting now
• A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors — Recruiting now
• A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer — Recruiting now
• A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment — Recruiting now